MECP2 and ventricular tachycardia: Using MeCP2 null mice and nervous-system-specific conditional MeCP2 knock-out (NKO) mice, McCauley et al. [14] demonstrated that deletion of MeCP2 in the nervous system alone was sufficient to cause QT prolongation and an increased susceptibility to ventricular tachycardia.